KevinNeilHolderMD

Cardiology • Tallahassee, FL

Cardiologist

Join to view full profile

Dr. Holder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Holder's full profile

Already have an account?

Office
2770 Capital Medical Blvd
Suite 109-C
Tallahassee, FL 32308
Is this information wrong?

Education & Training

Oregon Health & Science UniversityFellowship, Cardiovascular Disease, 2008 - 2011
Tulane UniversityResidency, Internal Medicine, 2005 - 2008
Brody School of Medicine at East Carolina UniversityClass of 2005

Certifications & Licensure

OR State Medical License 2009 - Present
FL State Medical License 2017 - 2026
NC State Medical License 2019 - 2023
TN State Medical License 2020 - 2022
WA State Medical License 2011 - 2018
LA State Medical License 2006 - 2009
American Board of Internal Medicine Cardiovascular Disease
Certification Board of Nuclear CardiologyDiplomate
National Board of EchocardiographyDiplomate- Adult Comprehensive Echocardiography

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

22 citations
Thiazolidinediones Up-regulate Insulin-like Growth Factor-1 Receptor via a Peroxisome Proliferator-activated Receptor γ-Independent Pathway
Yusuke Higashi, Kevin N. Holder, Patrice Delafontaine> ;The Journal of Biological Chemistry. 2010 Nov 19
137 citations
Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition
Bin Shan, Tso-Pang Yao, Hong T. Nguyen, Ying Zhuo, Dawn R. Levy, Ross C. Klingsberg, Hui Tao, Michael L. Palmer, Kevin N. Holder, Joseph A. Lasky> ;The Journal of Biological Chemistry. 2008 Jul 25
288 citations
Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.
Lydia A. Bazzano, Kristi Reynolds, Kevin N. Holder, Jiang He> ;JAMA. 2006 Dec 13

Abstracts/Posters

Potential Mechanism for Atheroprotective Effects of Thiazolidinediones: Upregulation of Vascular Smooth Muscle Insulin-Like Growth Factor-1 Receptor Expression and Sig...
Higashi,Y., Holder, K., Delafontaine, P., The Endocrine Society's 89th Annual Meeting, Toronto, 6/2007
Epstein-Barr Virus Latent Membrane Protein-1 Induces Epithelial-Mesenchymal Transition by Acting Synergistically with Transforming Growth Factor-1 in Human Lung Epithe...
R.C. Klingsberg, MD, J.A. Lasky, MD, E. Flemington, PhD, H.T. Nguyen, B.S., Y. Zhou, MD, K. Holder, MD and B. Shan, PhD, American Thoracic Society International Conference, 1/1/2007
A Novel Anti-Atherosclerotic Effect of the Thiazolidinedione Class of Peroxisome Proliferator Activated Receptor gamma Ligands: Upregulation of Vascular Smooth Muscle ...
Higashi Yuske, Holder Kevin, Delafontaine Patrick, Circulation. 2006, Oct 31 Supplemental Issue, AHA Scientific Sessions, 10/31/2006

Press Mentions

Briefcase: March 8March 8th, 2020

Hospital Affiliations

HCA Florida Capital HospitalTallahassee, Florida